RIG-I-like Receptor Triggering by Dengue Virus Drives Dendritic Cell Immune Activation and TH1 Differentiation.
Joris K SprokholtTanja M KapteinJohn L van HammeRonald J OvermarsSonja I GringhuisTeunis B H GeijtenbeekPublished in: Journal of immunology (Baltimore, Md. : 1950) (2017)
Dengue virus (DENV) causes 400 million infections annually and is one of several viruses that can cause viral hemorrhagic fever, which is characterized by uncontrolled immune activation resulting in high fever and internal bleeding. Although the underlying mechanisms are unknown, massive cytokine secretion is thought to be involved. Dendritic cells (DCs) are the main target cells of DENV, and we investigated their role in DENV-induced cytokine production and adaptive immune responses. DENV infection induced DC maturation and secretion of IL-1β, IL-6, and TNF. Inhibition of DENV RNA replication abrogated these responses. Notably, silencing of RNA sensors RIG-I or MDA5 abrogated DC maturation, as well as cytokine responses by DENV-infected DCs. DC maturation was induced by type I IFN responses because inhibition of IFN-α/β receptor signaling abrogated DENV-induced DC maturation. Moreover, DENV infection of DCs resulted in CCL2, CCL3, and CCL4 expression, which was abrogated after RIG-I and MDA5 silencing. DCs play an essential role in TH cell differentiation, and we show that RIG-I and MDA5 triggering by DENV leads to TH1 polarization, which is characterized by high levels of IFN-γ. Notably, cytokines IL-6, TNF, and IFN-γ and chemokines CCL2, CCL3, and CCL4 have been associated with disease severity, endothelial dysfunction, and vasodilation. Therefore, we identified RIG-I and MDA5 as critical players in innate and adaptive immune responses against DENV, and targeting these receptors has the potential to decrease hemorrhagic fever in patients.
Keyphrases
- dengue virus
- dendritic cells
- immune response
- zika virus
- liver injury
- aedes aegypti
- drug induced
- regulatory t cells
- liver fibrosis
- cell cycle arrest
- high glucose
- rheumatoid arthritis
- breast cancer cells
- end stage renal disease
- diabetic rats
- toll like receptor
- drug delivery
- sars cov
- poor prognosis
- cell death
- oxidative stress
- endothelial cells
- chronic kidney disease
- cancer therapy
- risk assessment
- endoplasmic reticulum stress